Overview

Autoimmune Disease Diagnosis Market is estimated to value over USD 6 billion by 2027 end with a CAGR of over 8.7% during the forecast period 2020 to 2027.

Rising occurrence of autoimmune diseases like type 1 diabetes in infants along with an increased demand for faster diagnostics are some of the key factors driving the autoimmune disease diagnosis market growth. Technological advancements and rising demand for laboratory automation shall bolster the market growth. Furthermore, several initiatives undertaken by the government like the North American Rheumatoid Arthritis Consortium, Autoimmunity Centres of Excellence and Cooperative study Group for Autoimmune Disease Prevention are continuously educating healthcare professional and patients pertaining to the treatment and diagnosis of autoimmune diseases. Moreover, soaring number of autoimmune disease patients has boosted the growth of the market. According to the data published by the American Autoimmune Related Diseases Association Inc., 2013, Americans were able to identify an autoimmune disease with a rise in 10%.

Market Segmentation:

By Product

Consumables and Assay Kits
Instruments

By Test Type

Inflammatory Markers
Routine laboratory Tests
Immunologic Tests and Autoantibodies Tests
Other Tests

By Disease

Rheumatoid Arthritis
Systemic Lupus Erythematous
Sjögren’s Syndrome
Thyroditis
Scleroderma
Other Diseases

By End User

Clinical Laboratories
Hospitals
Other End Users

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

The market is fragmented into product, test type, disease, end user and region. The disease segment is classified into systemic and localised disorders. The systemic diseases are rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematous and others while the localised disorders are divided into multiple sclerosis, type 1 diabetes, Hashimoto’s thyroiditis, idiopathic thrombocytopenic purpura and others. The localised disorders dominated the market owing to an increased patient volume. The product segment is divided into consumables and assay kits and instruments. The consumables and assay kits segment is anticipated to hold the largest autoimmune disease diagnosis market share and this can be credited to the increased prevalence of autoimmune diseases and rise in the number of approvals for diagnostic products. The test type segment is divided into inflammatory markers, routine laboratory tests, immunologic tests and autoantibodies tests and other tests. The routine laboratory test is predicted to lead the market, and this can be credited to the advancements in the healthcare infrastructure and rising adoption of these tests for regular diagnosis.

Regional Analysis:

The Europe region is expected to dominate the market and it is followed by the Asia Pacific region. This dominance can be attributed to the increased prevalence of appalling diseases, the rising ageing population and advancements in the healthcare infrastructure along with the increased disposable income.

Competitive Landscape:

The key market players included are F. Hoffmann-La Roche Ltd, Siemens Healthineers, Abbott Laboratories, Beckman Coulter Inc., SQI Diagnostics, Quest Diagnostics, EUROIMMUN AG, AESKU Diagnostics GmbH & Co. KG, INOVA Diagnostics Inc., Crescendo Bioscience Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Hemagen Diagnostics Inc.

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key market trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global autoimmune disease diagnosis market by product, by test type, by disease, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com